Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Donnelley Financial Solutions
DFIN
$1.19B
| $28.1M | ﹤0.01% |
498,866
-22,996
| -4% | -$1.12M |
|
1602
Madison Square Garden
MSGE
$3.7B
| $28M | ﹤0.01% |
851,253
+132,382
| +18% | +$4.37M |
|
1603
Agilysys
AGYS
$3.06B
| $27.9M | ﹤0.01% |
421,702
+18,741
| +5% | +$1.3M |
|
1604
World Kinect Corp
WKC
$2.03B
| $27.9M | ﹤0.01% |
1,243,094
+36,056
| +3% | +$804K |
|
|
ALEX
1605
DELISTED
Alexander & Baldwin
ALEX
| $27.9M | ﹤0.01% |
1,666,169
+70,285
| +4% | +$1.27M |
|
1606
Astrana Health
ASTH
$1.79B
| $27.8M | ﹤0.01% |
902,171
+40,348
| +5% | +$1.39M |
|
|
SOVO
1607
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $27.8M | ﹤0.01% |
1,234,220
+283,745
| +30% | +$5.97M |
|
1608
Dave & Buster's
PLAY
$402M
| $27.8M | ﹤0.01% |
750,422
-95,975
| -11% | -$3.92M |
|
|
NXGN
1609
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $27.8M | ﹤0.01% |
1,172,140
+52,755
| +5% | +$993K |
|
1610
Descartes Systems
DSGX
$6.62B
| $27.8M | ﹤0.01% |
375,076
+8,733
| +2% | +$659K |
|
|
HBI
1611
DELISTED
Hanesbrands
HBI
| $27.8M | ﹤0.01% |
7,019,352
+226,472
| +3% | +$1.1M |
|
1612
Hertz
HTZ
$477M
| $27.8M | ﹤0.01% |
2,268,391
-197,763
| -8% | -$3.31M |
|
1613
Tennant Co
TNC
$1.46B
| $27.8M | ﹤0.01% |
374,303
+14,994
| +4% | +$1.2M |
|
1614
Brinker International
EAT
$9.56B
| $27.7M | ﹤0.01% |
877,769
+33,708
| +4% | +$1.18M |
|
1615
Myriad Genetics
MYGN
$291M
| $27.7M | ﹤0.01% |
1,726,884
+62,037
| +4% | +$1.18M |
|
1616
BioCryst Pharmaceuticals
BCRX
$2.29B
| $27.7M | ﹤0.01% |
3,911,077
+78,522
| +2% | +$564K |
|
1617
Park National Corp
PRK
$3.8B
| $27.7M | ﹤0.01% |
292,919
+11,084
| +4% | +$1.15M |
|
1618
Northwest Bancshares
NWBI
$2.32B
| $27.7M | ﹤0.01% |
2,705,591
+107,518
| +4% | +$1.2M |
|
1619
National Beverage
FIZZ
$2.97B
| $27.7M | ﹤0.01% |
588,413
+16,740
| +3% | +$844K |
|
1620
InMode
INMD
$879M
| $27.6M | ﹤0.01% |
907,595
+45,008
| +5% | +$1.77M |
|
1621
Procept Biorobotics
PRCT
$1.03B
| $27.6M | ﹤0.01% |
842,205
+129,014
| +18% | +$4.4M |
|
1622
Celldex Therapeutics
CLDX
$2.97B
| $27.5M | ﹤0.01% |
1,000,425
+35,352
| +4% | +$1.11M |
|
|
ELME
1623
Elme Communities
ELME
$147M
| $27.3M | ﹤0.01% |
2,004,608
+71,564
| +4% | +$1.11M |
|
|
SWTX
1624
DELISTED
SpringWorks Therapeutics
SWTX
| $27.3M | ﹤0.01% |
1,182,110
+128,944
| +12% | +$3.53M |
|
1625
La-Z-Boy
LZB
$1.63B
| $27.3M | ﹤0.01% |
884,775
+33,095
| +4% | +$1.02M |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.